HomeProductsBioactive CompoundsProteaseDPP4Teneligliptin
Chemical structure of CAS 760937-92-6

Teneligliptin

CAS No.760937-92-6
MDL No.MFCD13195565
MFC22H30N6OS
MW426.60
InChI KeyWGRQANOPCQRCME-PMACEKPBSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Teneligliptin is an amino acid amide.

CAS No.760937-92-6
Product NameTeneligliptin

Biological Targets

DPP4

Associated Conditions

diabetes mellitus·type 2 diabetes mellitus
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Teneligliptin Promotes Bile Acid Synthesis and Attenuates Lipid Accumulation in Obese Mice by Targeting the KLF15-Fgf15 Pathway.

Chemical research in toxicology • Vol. 33, Issue 8 • 2020
PMID: 32639145DOI: 10.1021/acs.chemrestox.0c00192

The IUPHAR Guide to Immunopharmacology: connecting immunology and pharmacology.

Immunology • Vol. 160, Issue 1 • 2020
PMID: 32020584PMC: PMC7160657DOI: 10.1111/imm.13175

Safety and Efficacy of Teneligliptin in Patients with Type 2 Diabetes Mellitus and Impaired Renal Function: Interim Report from Post-marketing Surveillance.

Diabetes therapy : research, treatment and education of diabetes and related disorders • Vol. 9, Issue 3 • 2018
PMID: 29637459PMC: PMC5984919DOI: 10.1007/s13300-018-0416-2

Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.

Vascular pharmacology • Vol. 96-98 • 2017
PMID: 28347868DOI: 10.1016/j.vph.2017.03.003

Documentation